Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates

Dora M. Berman, Melissa A. Willman, Dongmei Han, Gary Kleiner, Norman M. Kenyon, Over Cabrera, Julie A. Karl, Roger W. Wiseman, David H. O’Connor, Amelia Bartholomew,

Diabetes · 2010 · 201 citations · 40 references

Abstract

MSCs may provide an important approach for enhancement of islet engraftment, thereby decreasing the numbers of islets needed to achieve insulin independence. Furthermore, MSCs may serve as a new, safe, and effective antirejection therapy.

References

40